May 28, 2021

Manchin, Capito Announce $2.5 Million for Research Initiatives at West Virginia University

Washington, DC – U.S. Senators Joe Manchin (D-WV) and Shelley Moore Capito (R-WV), members of the Senate Appropriations Committee, today announced $2,510,924 in funding through the U.S. Department of Health and Human Services (HHS) for research projects at West Virginia University (WVU). These projects include initiatives within aging research, vision research, neurodevelopmental education, and understanding of neonatal sepsis.

“West Virginia University continues to lead the nation in important and innovative research. I am pleased HHS is investing in several research projects at West Virginia University to study aging, vision, immunology and neurodevelopment,” Senator Manchin said. “I look forward to seeing the results of these essential research projects and I will continue to advocate for funding to support research projects in the Mountain State.”
“The research capabilities at West Virginia University continue to grow stronger because the dedication of our faculty and students, as well as investments like this. This funding will help expand the knowledge and understanding across several programs at WVU, and make a meaningful impact on the lives of West Virginians. I will continue to advocate for the resources WVU needs to properly support their research initiatives and capabilities,” Senator Capito said.
Individual awards listed below:
  •        West Virginia University Research Corporation: Leadership Education in Neurodevelopmental and Related Disorders Training$623,558
  •        West Virginia University: The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis – $541,783
  •        West Virginia University: Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis$509,627
  •        West Virginia University: Age-related changes in multi-behavioral reactive balance control – $455,956
  •        West Virginia University: Proline metabolism in retinal health – $380,000